Clinical Trial Update: An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use [Phase 4]

View source ↗

Summary

This is an open-label Phase 4 trial evaluating the efficacy of re-treatment with etanercept in psoriasis patients who previously used the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Florida Academic Dermatology Centers | Conditions: Psoriasis | Phase 4 | Status: UNKNOWN